June 2025
News
April 11, 2025
BIORON GmbH, founded in 2002, specializes in high-quality products for molecular biology and supplies a wide range of reagents, DNA and RNA products as well as customized solutions to meet the technical needs of biotechnological research, diagnostics and therapeutic applications. The company has established a strong position in the field of molecular biology, with a particular focus on supplying ethically sourced and highly pure human DNA products.
Human Placenta DNA / COT I Human DNA
A notable offering from BIORON GmbH is its Human Placenta DNA and COT I Human DNA products. These specialized DNA products are derived from human placental tissue, providing a relevant material with potential in genetic research, diagnostic testing, gene therapy development and other medical applications. Human Placenta DNA as raw material is mainly used for chromosomal and whole genome analysis, FISH, Southern-Blot, reduction of cross hybridization, construction of genomic libraries, background generation for PCR based sterilization assays and as a blocking reagent for various applications. COT I Human DNA, enriched for repetitive sequences, is valuable especially for NGS applications and is used for chromosomal and genomic analysis like mentioned before. It ensures high specificity and sensitivity in diagnostic assays and gene analysis. The company’s in-house human DNA production capabilities procure consistent quality control and compliance with global regulatory standards.
Focus on PCR Technologies and Diagnostics
Since its founding, the company has focused on molecular biological applications, particularly PCR, and on providing a comprehensive product portfolio to support these cutting-edge technologies. The company offers a wide range of PCR-related products, including enzymes, master mixes, reverse transcription products and related products like RNA and DNA-purification kits, nucleotides, DNA ladders, agarose and enzymes (e.g. UDG). These products are carefully designed to meet the rigorous performance requirements of both academic and commercial laboratories. Thereby, the high-performance products offered by BIORON are optimized for molecular diagnostics and genetic research, providing accurate and reliable results in a wide range of scientific research areas.
Regulatory Compliance and Quality Assurance
In an industry where regulatory compliance is paramount, BIORON GmbH maintains the ISO 13485:2016 certification (medical) and adheres to Good Manufacturing Practices (GMP) and to ensure that its products meet international standards. These practices guarantee that BIORON’s products are suitable for use in high-stakes applications, including clinical trials, diagnostic testing, and therapeutic development.
Custom Solutions for Biotechnology Applications
BIORON GmbH places a strong emphasis on customer service and custom solutions tailored to the specific needs of its clients in the biotechnology sector. The company is committed to offering customer specific product parameters, quality control measures, and personalized support throughout the development process. From initial small-scale samples to large-scale bulk orders, BIORON guarantees its customers at every stage comprehensive support, reliable cooperation and assistance in providing precise, high-quality solutions in various fields of biotechnology.
Conclusion
In conclusion, BIORON GmbH has established itself as an international key supplier for manufacturers, offering high-quality molecular biology products and specialized solutions for research, diagnostics, and therapeutic applications. The company’s focus on PCR technologies, Human Placenta DNA and COT I Human DNA products, as well as its commitment to regulatory compliance and the development of customized customer-focused solutions, makes it a trusted and proven partner in the biotechnology sector. With its comprehensive product portfolio and strong support throughout the development process, BIORON continues to contribute to progress in biotechnology research and medical applications.
February 20, 2025
Römerberg, Germany and Gaithersburg, MD, USA (February 20, 2025) – Areterna LLC, a subsidiary of Synthgene-Bio and pioneer with innovative Nucleic Acid and RNA products, established for the purpose of providing raw materials and services tailored to mRNA and oligonucleotide therapeutics, has entered into a further distribution agreement with Bion2, a specialist and distributor of molecular biological products headquartered in Czech Republic. This partnership aims to enhance accessibility to high-quality, cost-effective raw materials and services for mRNA and oligo research and manufacturing in the Czech Republic, Poland, Hungary, Slovenia, Slovakia, Romania and Bulgaria.
The collaboration between Synthgene-bio, BIORON and Bion2 marks a further significant step towards globalization and access to important resources for mRNA and oligo research and manufacturing in East Europe. This strategic alliance is determined to benefit customers by providing them with enhanced access to vital materials necessary for the advancement of mRNA and oligo-related initiatives.
This agreement marks a pivotal moment in Areterna’s mission to democratize mRNA vaccines and therapeutics, highlighting the company’s dedication to delivering GMP-grade raw materials at competitive prices. Simon Koerpert, Senior Director of Business Development EU at Areterna LLC, emphasized the importance of this partnership, stating, “Through our extension with BIORON and Bion2, we anticipate expanding our presence in the fast-growing markets, and aiming to offer more affordable raw materials to support mRNA therapeutics development.”